17 October 2017
News and Views
Links and Services
Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease, reports October's issue of Inflammatory Bowel Disease.
Dr Joćo Costa and colleagues systematically reviewed infliximab benefit in reduc
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors